Propanc Biopharma, Inc.
PPCB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $603 | $12 | $51 | $15 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $5 | $4 | $2 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $8,161 | $1 | $1 | $1 |
| Total Curr. Assets | $8,763 | $8,353 | $9,736 | $18 |
| Property Plant & Equip (Net) | $59 | $59 | $2 | $7 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $9,154 | $11,220 | $12,790 | $54 |
| Total NC Assets | $9,212 | $11,279 | $12,791 | $61 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $17,976 | $19,632 | $22,527 | $79 |
| Liabilities | – | – | – | – |
| Payables | $1,072 | $1,250 | $1,122 | $1,223 |
| Short-Term Debt | $127 | $1,562 | $1,151 | $1,119 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2,373 | $1,072 | $816 | $743 |
| Total Curr. Liab. | $3,572 | $5,578 | $4,341 | $4,155 |
| LT Debt | $42 | $106 | $94 | $82 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $42 | $147 | $94 | $82 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $63 | $59 | $2 | $7 |
| Total Liabilities | $3,615 | $5,726 | $4,435 | $4,237 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $13 | $12 | $12 | $0 |
| Retained Earnings | -$130,459 | -$125,622 | -$121,550 | -$67,483 |
| AOCI | $1,336 | $1,319 | $1,465 | $1,492 |
| Other Equity | $143,471 | $0 | $0 | $0 |
| Total Equity | $14,361 | $13,906 | $18,092 | -$4,159 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $17,976 | $19,632 | $22,527 | $79 |
| Net Debt | -$433 | $1,655 | $1,195 | $1,187 |